Effective Solutions to Global Problems
 
Extract from the Article Published in Invention Intilligence
NRDC,Govt of India Nov - Dec 2000
 
Chennai based Dr.JRK's Siddha Research & Pharmaceuticals Pvt. Ltd has brought out breakthroughs in skin diseases like Psoriasis & Vitiligo.
 
Rani Nagraj of Coimbatore had scaly lesions on her scalp legs and arms for over ten years and this condition worsened till in 1985 she consulted Dr. J.R. Krishnamoorthy, a Private Medical Practitioner at Kunrathur, 20 Kms off Chennai city through a reference made by her local Doctor. By then she had tried out most known treatments under modern medicine for such problems. She could recall how her father also had similar problems of the skin spread over his body. Under Dr. J.R. Krishnamoorthy's herbal treatment which continued for over two years she had a remarkable recovery from this long standing repulsive skin ailment of hers. She was suffering from Psoriasis.
 
Ganesh, 35, of Singapore, had been having reddish papules and patches over his body for over thirteen years and it was getting worse with time covering even his face. Till then he was treated with some steroidal applications that did little help to prevent recurrence. A Coal tar treatment also offered little relief.
 
Early in 1985, he heard of one 777 Oil as an effective solution for his problem through an Indian friend and decided to come to India. In his 25-day stay and treatment using the oil, his body was clear of the lesions. Back in Singapore he continued the medicine for a year and had no recurrence thereafter. Ganesh was a typical Psoriatic patient.
 
Rani Nagraj and Ganesh aren't the only people suffering from Psoriasis. Psoriasis is prevalent in all parts of the world and an estimated 2 % of the world population (nearly 4 crore) suffer from the disease.
 
Natures Wealth Restores Health
 
Dr. J.R.Krishnamoorthy had qualified in both Allopathic and Indian systems of Medicine and has a clinical practice at Kunrathur, Chennai for over 50 years. The interest in developing and highlighting the power of Indian System of Medicine in solving many problems ran through his career. Dr.J.R. Krishnamoorthy has been a Member, Consultant and Chairperson of many committees and establishments of the Ministry of Health, Government of India during the last 3 decades.
 
Formerly he was the Chairman of the Scientific Advisory Committee, Siddha CCRAS in the Ministry of Health and has been Honorary Consultant in the Central Council for Research in Ayurveda and Siddha (CCRAS) Govt.of India.
 
He is currently working on various projects initiated by the Institute for the treatment of AIDS.
 
In the mid 70s, based on a trigger received from a tribal source Dr.J.R. Krishnamoorthy identified the possible clinical use of a tropical herb for treatment of skin disorders like Psoriasis. Extensive literary clinical studies, done in his research wing, resulted in the evolution of the formulation 777 Oil.
 
Clinical trials at the CRI (S)
 
After successful clinical trials at his end, 777 Oil was further evaluated by the Central Research Institute for Siddha (CRI) (S), Chennai in the 80s and the clinical trials on over 300 Psoriasis patients was done by a team of scientists of CRI(S),Chenni (Unit of CCRAS) under the Guidence of Dr.J.R. Krishnamoorthy Honorary Consultant of CRI(S).
 
The study covered a target period of 12-16 weeks of treatment and a subsequent follow-up study over 2-4 years. The observations revealed that scaling stopped in 2-3 weeks, thickening reduced around 6-12 weeks and itching stopped. The study was done for both external application of 777 Oil and intake of 777 Oil.
 
In the follow-up study of 2-4 years, the CRI (S) reports that periodicity of recurrence postponed, intensity reduced and complications minimized or nil. In a study on associated problems in Psoriasis, Dr. Kalavathi et.al reported that there were no incidence of induced Diabetes mellitus, hypertension and gastric problems. The vital organs were normal.
 
Subsequently, CCRAS Patented 777 Oil under the National Research Development Corporation (NRDC), New Delhi, India acknowledged the studies.
 
An organisation to support a vision
 
In 1990, Dr. J.R. Krishnamoorthy promoted Dr. JRK 's Siddha Research & Pharmaceuticals Pvt. Ltd, a company that would engage itself in Research, Development, Manufacture and Marketing of products based on Indian Systems of Medicine.
 
The company began with a license to manufacture 777 Oil and another product PSOROLIN Ointment for Psoriasis and has today over 20 formulations based on Siddha Systems of Medicine. They include solutions to a variety of skin ailments like Vitiligo, Hyperkeratosis, etc., and cost effective solutions to acute musculo-skeletal pain related problems.
 
Dr. J.R.Krishnamoorthy has been the originator of many of the formulations manufactured by the company. He has clinically evaluated all products for at least 5-6 years before they were made available for the Marketing.
 
A preferred solution in all streams of medicine
 
Dr.JRK's Siddha Research & Pharmaceuticals Pvt. Ltd has successfully promoted its products to leading Modern Medical and Indian Medical practitioners in India. The company has established itself as an organization promoting well-researched and evaluated products based on Indian System of Medicine for some of the serious problems that find no definite solution in Modern Systems. Its products 777 Oil and Psorolin Ointment for the treatment of PSORIASIS and Tolenorm Oil & Ointment for VITILIGO have been considered as breakthrough products and have been widely accepted as the most preferred solution by most Dermatologists, General Practitioners of the Allopathic and Vaidhyas in Indian systems of Medicine.
 
On the Efficacy of Kesh Raksha, Dano, S.I.V.A drops, Pesin, Caratol-E, Bekay, G-7 and Capsules have been presented at National Conferences on ISM, held during the last 10 years.
 
Its products 777 Oil, PSOROLIN Ointment, TOLENORM and LIPPU have been evaluated at the Kilpauk Medical College Hospital, Chennai, Ram Manohar Lohia Hospital, New Delhi and the Government Stanley Medical College, Chennai. Clinical study and Research papers on their observations have been presented at the National and Regional Conferences of the Indian Association of Dermatologists, Venerologists and Leprologists (IADV&L) and in International Congress at Sydney.